Comprehensive Diagnostics of Diabetic Nephropathy by Transcriptome RNA Sequencing
Lei Lei,Yihua Bai,Yang Fan,Yaling Li,Hongying Jiang,Jiaping Wang
DOI: https://doi.org/10.2147/DMSO.S371026
2022-10-10
Abstract:Lei Lei, 1 Yihua Bai, 1 Yang Fan, 1 Yaling Li, 1 Hongying Jiang, 1 Jiaping Wang 2 1 Department of Nephrology, The Second Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, People's Republic of China; 2 Department of Radiology, The Second Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, People's Republic of China Correspondence: Yihua Bai, Department of Nephrology, The Second Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, People's Republic of China, Email Background: Diabetic nephropathy (DN) is a primary driver of end-stage renal disease. Given the heterogeneity of renal lesions and the complex mechanisms of DN, the present-day diagnostic approach remains highly controversial. We aimed to design a diagnostic model by bioinformatics methods for discriminating DN patients from normal subjects. Methods: In this study, transcriptome sequencing was performed on 6 clinical samples (3 from DN patients and 3 from healthy volunteers) from the Second Affiliated Hospital of Kunming Medical University. Construction of a competing endogenous RNA (ceRNA) network based on differentially expressed (DE)-mRNAs and -long noncoding RNAs (lncRNAs). Subsequently, the CytoHubba plugin was used to identify hub genes from DE-mRNAs in the ceRNA network and to perform functional enrichment analysis on them. The least absolute shrinkage and selection operator (LASSO) regression analysis was responsible for screening the diagnostic biomarkers from hub genes and assessing their diagnostic power using ROC curves. The pathways involved in hub genes were revealed by single-gene Gene Set Enrichment Analysis (GSEA). Moreover, we verified the expression levels of diagnostic biomarkers by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot. Results: A total of 10 hub genes were screened from the ceRNA network, which appeared to be associated with the viral infection, kidney development, and regulation of immune and inflammatory responses. Subsequently, LASSO regression analysis established a diagnostic model consisting of DDX58, SAMD9L , and TLR6 with a robust diagnostic potency (AUC = 1). Similarly, single-gene GSEA showed a strong association of these diagnostic biomarkers with the viral infection. Furthermore, PCR and Western blot demonstrated showed that DDX58, SAMD9L , and TLR6 were upregulated in DN patients at both transcriptome and protein levels compared to healthy controls. Conclusion: We confirmed that differentially expressed hub genes may be novel diagnostic biomarkers in DN. Keywords: diabetic nephropathy, DN, diagnosis, ceRNA, biomarker Diabetes mellitus (DM) is a serious problem affecting human health at present. The International Diabetes Federation estimates that the number of adults with diabetes in the world will rise to 643 million by 2030 and there will be more than 783 million adults living with diabetes in 2045 1 . More than that, the rising number of patients with diabetes has brought a huge economic burden on the medical and health care systems worldwide. 2 In addition to having great harm to the endocrine system, vascular-related complications caused by diabetes can also lead to multi-system damage. 3 Whereas microangiopathy in the kidney usually causes chronic kidney disease (CKD), which is often called DN 4 and is also one of the most important and serious microvascular complications of diabetes. 5 DN is the primary cause of end-stage renal disease (ESRD). 6 Long-term hyperglycemia could lead to the loss of kidney function, characterized by glomerular hypertrophy, albuminuria, decreased estimated glomerular filtration rate, and renal fibrosis. 7 It is generally believed that the pathogenesis of DN may be related to oxidative stress, activation of the RAAS system, inflammation and so on. 8,9 The early stage of DN is mainly shown in glomerular hyperfiltration, but with the progression of the disease, microalbuminuria, obvious albuminuria and progressive decrease of eGFR will be found, resulting in ESRD. 10 Currently, with evaluating the longtime of diabetes or the presence of diabetic retinopathy exception, the diagnosis of DN is mainly judged by persistent albuminuria and declining eGFR. 11,12 Although these biomarkers are widely used clinically, they are inevitably affected by age, gender, heredity, and other factors. In addition, a single biomarker does not have the precise ability to predict disease. 13 For example, some studies have shown that microalbuminuria was considered to be the prime indicator of DN though, it was not as -Abstract Truncated-